Distinct toll-like receptor signals regulate cerebral parasite load and interferon α/β and tumor necrosis factor α-dependent T-cell infiltration in the brains of trypanosoma brucei-infected mice

Journal of Infectious Diseases

Volumn 205, Issue 2, 2012, Pages 320-332

  Amin, Daniel Ndem ^a   Vodnala, Suman K ^a   Masocha, Willias ^b   Sun, Bo ^a,c   Kristensson, Krister ^a   Rottenberg, Martin E ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KUWAIT UNIVERSITY   (Kuwait)

^c HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA INTERFERON RECEPTOR; BETA INTERFERON; BETA INTERFERON RECEPTOR; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; EMBRYO; IMMUNOPATHOGENESIS; INFLAMMATORY CELL; INNATE IMMUNITY; LYMPHOCYTIC INFILTRATION; MICROGLIA; MOUSE; NAGANA; NONHUMAN; PARASITE CONTROL; PARASITE LOAD; PARASITEMIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; IMMUNITY, INNATE; INTERFERON-BETA; INTERFERON-GAMMA; MICE; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PARASITE LOAD; PARASITEMIA; RECEPTOR, INTERFERON ALPHA-BETA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 9; TRYPANOSOMA BRUCEI BRUCEI; TRYPANOSOMIASIS, AFRICAN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84555186966     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir734     Document Type: Article

References (49)

1. Dumas M, Bisser S. Clinical aspects of human African trypanosomiasis. In: Dumas M, Bouteille B, Buguet A, eds. Progress in human African trypanosomiasis, sleeping sickness. Paris: Springer, 1999; 215-33.
2. Kibona SN, Matemba L, Kaboya JS, Lubega GW. Drug-resistance of Trypanosoma B. rhodesiense isolates from Tanzania. Trop Med Int Health 2006; 11:144-55.
3. Kristensson K, Mhlanga JD, Bentivoglio M. Parasites and the brain: neuroinvasion, immunopathogenesis and neuronal dysfunctions. Curr Top Microbiol Immunol 2002; 265:227-57. (Pubitemid 34241987)
4. Masocha W, Robertson B, Rottenberg ME, Mhlanga J, Sorokin L, Kristensson K. Cerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the blood-brain barrier. J Clin Invest 2004; 114:689-94. (Pubitemid 39578759)
5. Kristensson K, Nygard M, Bertini G, Bentivoglio M. African trypanosome infections of the nervous system: parasite entry and effects on sleep and synaptic functions. Prog Neurobiol 2010; 91:152-71.
6. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010; 140:805-20.
7. Drennan MB, Stijlemans B, Van den Abbeele J, et al. The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent. J Immunol 2005; 175:2501-9. (Pubitemid 41113861)
8. Feng CG, Scanga CA, Collazo-Custodio CM, et al. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)-and TLR4-deficient animals. J Immunol 2003; 171:4758-64. (Pubitemid 37310594)
9. Rothfuchs AG, Trumstedt C, Wigzell H, Rottenberg ME. Intracellular bacterial infection-induced IFN-gamma is critically but not solely dependent on Toll-like receptor 4-myeloid differentiation factor 88-IFN-alpha beta-STAT1 signaling. J Immunol 2004; 172: 6345-53. (Pubitemid 38621243)
10. Amin DN, Rottenberg ME, Thomsen AR, et al. Expression and role of CXCL10 during the encephalitic stage of experimental and clinical African trypanosomiasis. J Infect Dis 2009; 200:1556-65.
11. Mulenga C, Mhlanga JD, Kristensson K, Robertson B. Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic diseasemodel. Neuropathol Appl Neurobiol 2001; 27:77-85. (Pubitemid 32291190)
12. Mankowski JL, Queen SE, Tarwater PM, Fox KJ, Perry VH. Accumulation of beta-amyloid precursor protein in axons correlates with CNS expression of SIV gp41. J Neuropathol Exp Neurol 2002; 61:85-90. (Pubitemid 34027723)
13. Yang T, Stark P, Janik K, Wigzell H, Rottenberg ME. SOCS-1 protects against Chlamydia pneumoniae-induced lethal inflammation but hampers effective bacterial clearance. J Immunol 2008; 180:4040-9.
14. Bafica A, Santiago HC, Goldszmid R, Ropert C, Gazzinelli RT, Sher A. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J Immunol 2006; 177:3515-19. (Pubitemid 44359881)
15. Minty A, Chalon P, Derocq JM, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993; 362:248-50. (Pubitemid 23093630)
16. Reid DM, Perry VH, Andersson PB, Gordon S. Mitosis and apoptosis of microglia in vivo induced by an anti-CR3 antibody which crosses the blood-brain barrier. Neuroscience 1993; 56:529-33. (Pubitemid 23290568)
17. Fitzgerald KA, Chen ZJ. Sorting out Toll signals. Cell 2006; 125:834-6. (Pubitemid 43795201)
18. Magez S, Radwanska M, Beschin A, Sekikawa K, De Baetselier P. Tumor necrosis factor alpha is a key mediator in the regulation of experimental Trypanosoma brucei infections. Infect Immun 1999; 67:3128-32. (Pubitemid 29244739)
19. Sileghem M, Flynn JN, Logan-Henfrey L, Ellis J. Tumour necrosis factor production by monocytes from cattle infected with Trypanosoma (Duttonella) vivax and Trypanosoma (Nannomonas) congolense: possible association with severity of anaemia associated with the disease. Parasite Immunol 1994; 16:51-4. (Pubitemid 24176420)
20. Okomo-Assoumou MC, Daulouede S, Lemesre JL, N'Zila-Mouanda A, Vincendeau P. Correlation of high serum levels of tumor necrosis factor-alpha with disease severity in human African trypanosomiasis. Am J Trop Med Hyg 1995; 53:539-43.
21. Peschon JJ, Torrance DS, Stocking KL, et al. TNF receptor-deficientmice reveal divergent roles for p55 and p75 in severalmodels of inflammation. J Immunol 1998; 160:943-52. (Pubitemid 28049339)
22. Osborn L, Hession C, Tizard R, et al. Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes. Cell 1989; 59:1203-11. (Pubitemid 20024630)
23. Bevilacqua MP, Stengelin S, Gimbrone MA Jr, Seed B. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 1989; 243:1160-5. (Pubitemid 19081142)
24. Harris TH, Mansfield JM, Paulnock DM. CpG oligodeoxynucleotide treatment enhances innate resistance and acquired immunity to African trypanosomes. Infect Immun 2007; 75:2366-73. (Pubitemid 46744326)
25. Shoda LK, Kegerreis KA, Suarez CE, et al. DNA fromprotozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulatesmacrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide. Infect Immun 2001; 69:2162-71. (Pubitemid 32239682)
26. Lopez R, Demick KP, Mansfield JM, Paulnock DM. Type I IFNs play a role in early resistance, but subsequent susceptibility, to the African trypanosomes. J Immunol 2008; 181:4908-17.
27. Le Bon A, Etchart N, Rossmann C, et al. Cross-priming of CD81 T cells stimulated by virus-induced type I interferon. Nat Immunol 2003; 4:1009-15. (Pubitemid 37265922)
28. Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 2001; 14:461-70. (Pubitemid 32441598)
29. Thomsen AR. Lymphocytic choriomeningitis virus-induced central nervous system disease: a model for studying the role of chemokines in regulating the acute antiviral CD81 T-cell response in an immuneprivileged organ. J Virol 2009; 83:20-8.
30. Aksoy E, Zouain CS, Vanhoutte F, et al. Double-stranded RNAs from the helminth parasite Schistosoma activate TLR3 in dendritic cells. J Biol Chem 2005; 280:277-83. (Pubitemid 40164990)
31. Ullu E, Tschudi C, Chakraborty T. RNA interference in protozoan parasites. Cell Microbiol 2004; 6:509-19. (Pubitemid 38618662)
32. Chessler AD, Ferreira LR, Chang TH, Fitzgerald KA, Burleigh BA. A novel IFN regulatory factor 3-dependent pathway activated by trypanosomes triggers IFN-beta inmacrophages and fibroblasts. J Immunol 2008; 181:7917-24.
33. Minagar A, Alexander JS. Blood-brain barrier disruption in multiple sclerosis. Mult Scler 2003; 9:540-9. (Pubitemid 37479401)
34. Zeni P, Doepker E, Schulze-Topphoff U, Huewel S, Tenenbaum T, Galla HJ. MMPs contribute to TNF-alpha-induced alteration of the blood-cerebrospinal fluid barrier in vitro. Am J Physiol Cell Physiol 2007; 293:C855-64. (Pubitemid 47437399)
35. Hanemaaijer R, Koolwijk P, le Clercq L, de VreeWJ, van HinsberghVW. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J 1993; 296:803-9. (Pubitemid 24008200)
36. Johnatty RN, Taub DD, Reeder SP, et al. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J Immunol 1997; 158:2327-33. (Pubitemid 127470018)
37. Bafica A, Scanga CA, Feng CG, Leifer C, Cheever A, Sher A. TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis. J Exp Med 2005; 202: 1715-24. (Pubitemid 41815877)
38. Sorensen LN, Reinert LS, Malmgaard L, Bartholdy C, Thomsen AR, Paludan SR. TLR2 and TLR9 synergistically control herpes simplex virus infection in the brain. J Immunol 2008; 181:8604-12.
39. Appledorn DM, Patial S, McBride A, et al. Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. J Immunol 2008; 181:2134-44.
40. Lee KS, Scanga CA, Bachelder EM, Chen Q, Snapper CM. TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae. Cell Immunol 2007; 245:103-10. (Pubitemid 46921170)
41. Campos MA, Almeida IC, Takeuchi O, et al. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J Immunol 2001; 167:416-23. (Pubitemid 32567807)
42. Olson JK, Miller SD. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 2004; 173:3916-24. (Pubitemid 39280755)
43. Wei G, Bull H, Zhou X, Tabel H. Intradermal infections of mice by low numbers of African trypanosomes are controlled by innate resistance but enhance susceptibility to reinfection. J Infect Dis 2011; 203:418-29.
44. Amrouni D, Gautier-Sauvigne S, Meiller A, et al. Cerebral and peripheral changes occurring in nitric oxide (NO) synthesis in a rat model of sleeping sickness: identification of brain iNOS expressing cells. PLoS One 2010; 5:e9211.
45. McGwire BS, Olson CL, Tack BF, Engman DM. Killing of African trypanosomes by antimicrobial peptides. J Infect Dis 2003; 188:146-52. (Pubitemid 36829755)
46. Gobert AP, Semballa S, Daulouede S, et al. Murine macrophages use oxygen-and nitric oxide-dependent mechanisms to synthesize S-nitroso-albumin and to kill extracellular trypanosomes. Infect Immun 1998; 66:4068-72. (Pubitemid 28402673)
47. Figarella K, Rawer M, Uzcategui NL, et al. Prostaglandin D2 induces programmed cell death in Trypanosoma brucei bloodstream form. Cell Death Differ 2005; 12:335-46. (Pubitemid 40520685)
48. Delgado M, Anderson P, Garcia-Salcedo JA, Caro M, Gonzalez-Rey E. Neuropeptides kill African trypanosomes by targeting intracellular compartments and inducing autophagic-like cell death. Cell Death Differ 2009; 16:406-16.
49. Jennings FW, Hunter CA, Kennedy PG, Murray M. Chemotherapy of Trypanosoma brucei infection of the central nervous system: the use of a rapid chemotherapeutic regimen and the development of post-treatment encephalopathies. Trans R Soc Trop Med Hyg 1993; 87:224-6.